The investment round was led by Pfizer Venture Investments and VC Novo Seeds together with the existing investor Industrifonden.
AMRA has developed a method for measuring body fat and muscle mass using a magnetic camera. The company’s aim is to assess the risk of serious illness based upon the patient’s body profile. The investment round facilitates an international establishment and an expanded network among leading pharmaceutical companies.
Vinge’s team consisted of Johan Larsson and Johan Mattsson.
